Then, we performed a first screening for TM9SF4 mRNA expression in primary leukemic blasts obtained from AML patients pertaining from the M0 to M5 subtypes following the FAB classification (Fig 1G). Here, TM9SF4 is linked to acute myeloid leukemia.